Standard versus extended criteria graft procurement. Experience at the Hospital de Especialidades La Raza

Main Article Content

Olga Estefanía Facio-Olvera
María del Pilar Cruz-Domínguez
Bertha Angélica García-García
Carlos Ocampo-Ramírez

Keywords

Expanded Criteria Donor, Standard Donor, Tissue and Organ Procurement, Organ Transplantation, Brain Death

Abstract

Background: In Mexico, there are 23 158 patients waiting for an organ or tissue transplant. The increasing demand of grafts justifies the use of expanded criteria donors; however, not even all standard grafts have been procured.


Objective: To identify the associated factors to the decision of not procuring grafts from brain death donors whose donation was consented.


Method: Retrospective cohort, univariate and multivariate analysis. 35 donation files with brain death were included from 2014 to 2019. Groups in which the heart wasn’t procured versus those in which it was procured were compared; same comparisons were made for liver, kidney, skin, bone tissue and corneas.


Results: 20 women (57.1%), 15 men (42.9%) average age of 43.8 ± 16.4 years. High-dose of inotropic or norepinephrine use increased the probability of cardiac procurement (odds ratio [OR] 0.57; 95% confidence interval [95%CI]: 0.0-0.5). It was not detected a sensitive and specific variable for decision making at liver procurement. Implementation of two or more diagnostic methods for BD were associated with kidney loss (OR: 10; 95%CI: 1.2-78.1). Organs and tissues met standard criteria; however, 76 (41.5%) were not procured.


Conclusions: Non-procurement associated factors were different from the standard donor established criteria. It is necessary to follow clear procurement criteria, in order to reduce viable grafts loss.

Abstract 182 | PDF (Spanish) Downloads 65 HTML (Spanish) Downloads 152

References

1. Escudero D, Otero J. Medicina intensiva y donación de órganos. ¿Explorando las últimas fronteras?Med Intensiva. 2015;39(6):366-74.

2. Centro Nacional de Trasplantes. Reporte anual 2019 de Donación y Trasplantes en México;2019. (Consultado 23 de febrero de 2020). Disponible en:https://www.gob.mx/cms/uploads/attachment/file/528301/Presentacion_anual_2019.pdf

3. Miranda B, Cuende N, Cañon J, Fernández Zincke E, Naya MT, Garrido G. Características de los donantes renales en España:factores de riesgo y órganos desechados para trasplante. Nefrologia. 2001;21(4):111-8.

4. Razdan M, Degenholtz H, Kahn J, Driessen J. Breakdown in the organ donation process and its effect on organ availability. J Transplant. 2015;2015:831501.

5. Llancaqueo M. Protocolos de selección y estudio del donante y receptor aplicables a la práctica chilena, en trasplante cardiaco.Rev Med Clin Las Condes. 2010;21(2):199-207.

6. Marasco S, Kras A, Schulberg E, Vale M, Chan P, Lee GA, et al. Donor brain death time and impact on outcomes in heart transplantation. Transplant Proc. 2013;45(1):33-7.

7. European Association for the Study of the Liver. EASL Clinical Practice Guidelines:Liver Transplantation. J Hepatol. 2016;64:433-85.

8. Martínez-Vaquera S, Navarro-Cabello MD, López-Andreu M, Dueñas-Jurado JM, Rodelo-Haad C, Ortega-Salas R, et al. Outcomes in renal transplantation with expanded-criteria donors. Transplant Proc. 2013;45(10):3595-8.

9. Aristizabal A, Castrillon Y, Gil T, Restrepo D, Solano K, Guevara M, et al. Manejo actual del donante potencial de órganos y tejidos en muerte cerebral:guía de manejo y revisión de la literatura. Rev Colomb Cir. 2017;32:128-45.

10. Organización Nacional de Trasplantes. Plan Nacional de Córneas. Madrid:Ministerio de Sanidad, Servicios Sociales e Igualdad;2016. (Consultado el 23 de febrero de 2020.) Disponible en:http://www.ont.es/infesp/Documents/PLAN%20NACIONAL%20DE%20CORNEAS%202016.pdf

11. Martínez-Flores F, Sandoval-Zamora H, Machuca-Rodríguez C, Barrera-López A, García-Cavazos R, Madinaveitia-Villanueva JA. Banco de piel y tejidos:un modelo operativo para la recuperacio?n y preservacio?n de aloinjertos de piel y tejidos. Cir Cir. 2015;84(1):85-92.

12. El Hage S, Dos Santos MJ, de Moraes EL, de Barros E Silva LB. Bone tissue donation:tendency and hurdles. Transp Proc. 2018;50(2):394-96.

13. Seguchi O, Fujita T, Murata Y, Sunami H, Sato T, Wantabe T, et al. Incidence, etiology, and outcome of primary graft dysfunction in adult heart transplant recipients:a single-center experience in Japan. Heart Vessels. 2016;31(4):555-62.

14. Smits JM, De Pauw M, de Vries E, Rahmel A, Meiser B, Laufer G, et al. Donor scoring system for heart transplantation and the impact on patient survival. J Heart Lung Transplant. 2012;31(4):387-97.

15. Chamorro-Jambrina C, Muñoz-Ramírez MR, Martínez-Melgar JL, Pérez-Cornejo MS. Organ donor management:eight common recommendations and actions that deserve reflection. Med Intensiva. 2018;41(9):559-68.

16. Singal A, Fang X, Kaif M, Hasanin M, Mcguire BM, Kuo YF, et al. Primary biliary cirrhosis has high wait-list mortality among patients listed for liver transplantation. Transpl Int. 2017;30(5):454-62.

17. Vodkin I, Kuo A. Extended criteria donors in liver transplantation. Clin Liver Dis. 2017;21(2):289-301.

18. Ko KJ, Kim YH, Kwon KH, Kim MH, Jun KW, Hwang JK, et al. Kidney transplantation using expanded criteria deceased donors and non-expanded-criteria deceased donors. Transplant Proc. 2018;50(10):3222-27.

19. Melilli E, Bestard O, Cruzado JM, Navarro Zorrita I, GrinyóMF, Martínez Castelao A. Trasplante de riñones con criterios expandidos:manejo y resultados a largo plazo. Nefrologia Sup Ext. 2011;2(5):98-104.

20. Domagala P, Gorski L, Wszola M, Kieszek R, Diuwe P, Drozdowski A, et al. Successful transplantation of kidneys from deceased donors with terminal acute kidney injury. Ren Fail. 2019;41(1):167-74.

21. Escudero D, Matesanz R, Soratti CA, Flores J. Muerte encefálica en Iberoamérica. Med Intensiva. 2009;33(9):415-23.

22. Ley General de Salud. Título Decimocuarto:Donación, Trasplantes y Pérdida de la Vida. México:Secretaría de Salud;1984. (Actualizado el 18 diciembre de 2007;consultado el 23 de febrero de 2020.) Disponible en:http://www.salud.gob.mx/unidades/cdi/legis/lgs/index-t14.htm

23. Rivera-Durón E, Portillo-García F, Tenango-Soriano V, González-Moreno F, Vázquez-Salinas C. Negativa familiar en un proceso de donacio?n. Arch Neurocien. 2014;19(2):83-7.

24. Miller C, Breakwell R. What factors influence a family's decisions to agree to organ donation?A critical literature review. London J Prim Care. 2018;10(4):103-07.

25. Siqueira M, Affonso C, de Aguilar B, Schirmer J. Indicadores de eficiencia no processo de doacao e trasplante de orgaos:revisao sistemática de la literatura. Rev Panam Salud Pública. 2016;40(2):90-7.

26. Squires J, Graham N, Coughlin M, ChasséM, Linklater S, Greenough M, et al. Barriers and enablers to organ donation after circulatory determination of death:a qualitative study exploring the beliefs of frontline intensive care unit professionals and organ donor coordinators. Transplant Direct. 2018;4(7):1-11.

27. Matesanz R, Domínguez-Gil B. Strategies to optimize deceased organ donation. Transp Rev. 2007;21(4):177-88.

28. Matesanz R, Domínguez-Gil B, Coll E, De la Rosa G, Marazuela R. Spanish experience as a leading country:what kind or measures were taken?Transpl Int. 2011;24(4):333-43.

29. Organización Nacional de Trasplantes. Actividad de Donación y Trasplante Hepático España 2018. Madrid:Ministerio de Sanidad, Servicios Sociales e Igualdad;2018. (Consultado el 23 de febrero de 2020.) Disponible en:http://www.ont.es/infesp/Memorias/Actividad%20de%20Donaci%C3%B3n%20y%20Trasplante%20Hep%C3%A1tico.pdf

30. Caballero F, Matesanz R. Manual de donación y trasplantes de órganos humanos. España:Organización Nacional de Trasplantes;31 de diciembre de 2015. (Consultado el 23 de febrero de 2020.) Disponible en:http://www.ont.es/publicaciones/Documents/Manual%20Donaci%C3%B3n%20y%20Trasplante%20%C3%93rganos%20Humanos-Dr%20%20F%20Caballero%20y%20Dr%20%20R%20Matesanz-2015.pdf